Brief: Fusion Antibodies Anticipates Revenues For FY2024 To Be Significantly Weighted Towards Second Half Of Financial Year
09/11/2023 07:26
Nov 9 (Reuters) - Fusion Antibodies PLC FAB.L :
* FUSION ANTIBODIES - HALF YEAR TRADING UPDATE
* FUSION ANTIBODIES PLC - STILL ANTICIPATES THAT REVENUES
FOR
FY2024 WILL BE SIGNIFICANTLY WEIGHTED TOWARDS SECOND HALF OF
FINANCIAL YEAR
Source text for Eikon: ID:nRSI8666Sa
Further company coverage: FAB.L
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM